These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15199208)

  • 1. After all those fat years: renal consequences of obesity.
    Bosma RJ; de Jong PE; Navis G
    Nephrol Dial Transplant; 2004 Jul; 19(7):1934. PubMed ID: 15199208
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
    Sarafidis PA
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between body fat distribution and renal damage in Chinese with obesity.
    Chen H; Liu Z; Li S; Chen Y; Yang B; Cai J; Wang Q; Li L
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):99-103. PubMed ID: 18095240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of obesity in children on kidney].
    Roszkowska-Blaim M
    Przegl Lek; 2006; 63 Suppl 3():25-8. PubMed ID: 16898481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.
    Ades PA; Savage PD; Toth MJ; Schneider DJ; Audelin MC; Bunn JY; Ludlow M
    Int J Obes (Lond); 2008 Jun; 32(6):967-74. PubMed ID: 18268512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Overweight and obesity--risk factors in the development and progression of renal disease].
    Sebeková K; Klassen A; Bahner U; Heidland A
    Vnitr Lek; 2004 Jul; 50(7):544-9. PubMed ID: 15323263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, insulin resistance, and renal function.
    Knight SF; Imig JD
    Microcirculation; 2007; 14(4-5):349-62. PubMed ID: 17613807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal affection in obesity].
    Saginova EA; Fomin VV; Moiseev SV; Lebedeva MV
    Ter Arkh; 2007; 79(6):88-93. PubMed ID: 17684978
    [No Abstract]   [Full Text] [Related]  

  • 11. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance?
    Schelling JR; Sedor JR
    J Am Soc Nephrol; 2004 Nov; 15(11):2773-4. PubMed ID: 15504930
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable?
    Hallan S; de Mutsert R; Carlsen S; Dekker FW; Aasarød K; Holmen J
    Am J Kidney Dis; 2006 Mar; 47(3):396-405. PubMed ID: 16490617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of obesity on development of chronic renal allograft dysfunction.
    Hamidian Jahromi A; Jalali GA; Roozbeh J
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):375-7. PubMed ID: 19414937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of change in waist circumference on cardiometabolic risk factors over 9 years: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
    Balkau B; Picard P; Vol S; Fezeu L; Eschwège E;
    Diabetes Care; 2007 Jul; 30(7):1901-3. PubMed ID: 17468349
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nephrological aspects of obesity].
    Krasnova EA; Moiseev SV; Fomin VV
    Klin Med (Mosk); 2005; 83(4):9-14. PubMed ID: 15941135
    [No Abstract]   [Full Text] [Related]  

  • 19. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
    Völler H; Schmailzl KJ; Bjarnason-Wehrens B
    Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.